Related Experiment Videos

Fungal infection in acute necrotizing pancreatitis

M Grewe1, G G Tsiotos, E Luque de-Leon

  • 1Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

Abstract

Insights

Fungal infections in necrotizing pancreatitis (NP) patients lead to worse outcomes than bacterial infections. Early antifungal prophylaxis is recommended for managing NP to improve patient survival and clinical course.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Critical Care Medicine

Background:

  • Necrotizing pancreatitis (NP) is a severe condition where fungal infections are anecdotally linked to poorer patient outcomes compared to bacterial infections.
  • This study aimed to compare the clinical progression and outcomes of patients with NP experiencing fungal infections versus nonfungal (primarily bacterial) infections.

Purpose of the Study:

  • To compare the clinical course and outcomes of patients with fungal versus bacterial infections in necrotizing pancreatitis.
  • To evaluate the impact of fungal infection on patient morbidity and mortality in NP.

Main Methods:

  • A prospective review of data from 57 patients diagnosed with infected NP between 1983 and 1995.
  • Comparison of clinical characteristics, treatment, and outcomes between patients with fungal (n=7) and bacterial (n=50) NP.

Main Results:

  • Fungal NP occurred in 12% of cases, with similar initial severity (APACHE-II scores) and causes (ERCP-induced) compared to bacterial NP.
  • Patients with fungal NP experienced longer antibiotic treatment, higher rates of mechanical ventilation, and significantly longer intensive care unit (ICU) and hospital stays.
  • Mortality was substantially higher in the fungal NP group (43%) compared to the bacterial NP group (20%).

Conclusions:

  • Fungal infection in necrotizing pancreatitis is associated with a more complicated clinical course and worse patient outcomes, despite similar initial disease severity.
  • The findings suggest that current management of NP may not adequately address fungal pathogens.
  • Low-dose antifungal prophylaxis should be considered as an early component of NP management to potentially improve outcomes.

Related Concept Videos